{"ticker": {"uuid": "bf488555-cd8c-4686-bce0-f8f6577832ee", "symbol": "688221", "name": "Frontier Biotechnologies Inc.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "ETFs Investing in Frontier Biotechnologies Inc. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFBGWTBnbVJCa1Z6ZEJNZ1MwLXNmajFyNlRLT0pIVi15RXNrM1VGalprMDFvRDhvZVhuOC0xdnBfUG1UQjN0QVQwWDBiaHJWeDVnU2lfWmNqZFJtTUQ1VGhkTzNR?oc=5", "source_name": "TradingView", "published_at": "2026-07-22T07:15:34+00:00", "published_display": "22 Jul 2026 07:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK nabs two Frontier Biotech siRNA assets in $1B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNSzRjcWJpeHlTZjIzZWhReUhZeVAtNHRsU0pnYjBsSEt1RUYtdHJPQVhldTdzYjB5V01WM0R2TU5YTlk3RnFzc3lUd2NNQjFrNy1EWDFDZ254VlNCXzVIdmFGY2dpZXpnVGNWa2hseF91MDNsbzMxSGpNbGl2WWs2a2FxNlFXN25PbmNEaTNua3ljamRNVDZPOWNR?oc=5", "source_name": "BioWorld News", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2022-08-08T07:00:00+00:00", "published_display": "08 Aug 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Frontier Biotechnologies' First Long-acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxQNkx0dE9iNUw3a3BXRV9OcUJybDAtNlpEbzNKRWxxOU1vT0FCNUd0NGlsb2x5OEdzVDhILWlxYU5OVVB4WTJHYmVWUXlyenpQejlBSzZJVFVMZVpOUjhxbVFiMjB0MmNCNXNLckFYX0I0ek80RUxkb1NfMWtVM3pCRkdTZ1VBSThPbGY0aC12OVpZZDRxc19ScHREREtFTlNJMlVxMmliUnRCZjRneEhsN0l3VHcwNGJFbzg0TG5XWUl4a3NrUjFWbHI3UUxMdkNUVFZSOXVZXzBqbmRvNUFMVi1fTzF0TWtHc2xzSkhhR3BMOUlkUE1sSy0xaEdhOHpnRmgwNmhINEY4b09YWXZsNERXVjctRHRLMjIw?oc=5", "source_name": "PR Newswire", "published_at": "2021-07-19T07:00:00+00:00", "published_display": "19 Jul 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ETFs Investing in Frontier Biotechnologies Inc. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFBGWTBnbVJCa1Z6ZEJNZ1MwLXNmajFyNlRLT0pIVi15RXNrM1VGalprMDFvRDhvZVhuOC0xdnBfUG1UQjN0QVQwWDBiaHJWeDVnU2lfWmNqZFJtTUQ1VGhkTzNR?oc=5", "source_name": "TradingView", "published_at": "2026-07-22T07:15:34+00:00", "published_display": "22 Jul 2026 07:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK nabs two Frontier Biotech siRNA assets in $1B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNSzRjcWJpeHlTZjIzZWhReUhZeVAtNHRsU0pnYjBsSEt1RUYtdHJPQVhldTdzYjB5V01WM0R2TU5YTlk3RnFzc3lUd2NNQjFrNy1EWDFDZ254VlNCXzVIdmFGY2dpZXpnVGNWa2hseF91MDNsbzMxSGpNbGl2WWs2a2FxNlFXN25PbmNEaTNua3ljamRNVDZPOWNR?oc=5", "source_name": "BioWorld News", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2022-08-08T07:00:00+00:00", "published_display": "08 Aug 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Frontier Biotechnologies' First Long-acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxQNkx0dE9iNUw3a3BXRV9OcUJybDAtNlpEbzNKRWxxOU1vT0FCNUd0NGlsb2x5OEdzVDhILWlxYU5OVVB4WTJHYmVWUXlyenpQejlBSzZJVFVMZVpOUjhxbVFiMjB0MmNCNXNLckFYX0I0ek80RUxkb1NfMWtVM3pCRkdTZ1VBSThPbGY0aC12OVpZZDRxc19ScHREREtFTlNJMlVxMmliUnRCZjRneEhsN0l3VHcwNGJFbzg0TG5XWUl4a3NrUjFWbHI3UUxMdkNUVFZSOXVZXzBqbmRvNUFMVi1fTzF0TWtHc2xzSkhhR3BMOUlkUE1sSy0xaEdhOHpnRmgwNmhINEY4b09YWXZsNERXVjctRHRLMjIw?oc=5", "source_name": "PR Newswire", "published_at": "2021-07-19T07:00:00+00:00", "published_display": "19 Jul 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 45, "total_relevant": 4, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 3, "score": 53, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 62, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 20.95, "latest_week": "2026-07-17", "one_week_move": -23.3, "four_week_move": 12.3, "twelve_week_move": 10.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.798863, "market_dynamics_buy_signal": false, "relative_strength": 11.602702, "fair_value_gap": 71.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.7792, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-23.3% over one week, +12.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-23.3% over one week, +12.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ETFs Investing in Frontier Biotechnologies Inc. Class A Stocks"}], "updated_at": "2026-07-23T08:42:52.715781+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}